
Tobacco company Altria (NYSE: MO) will be reporting results this Thursday morning. Here’s what you need to know.
Altria beat analysts’ revenue expectations last quarter, reporting revenues of $4.76 billion, up 5.3% year on year. It was a strong quarter for the company, with a beat of analysts’ EPS estimates and a narrow beat of analysts’ gross margin estimates.
Is Altria a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Altria’s revenue to grow 1.1% year on year, in line with its flat revenue from the same quarter last year.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Altria has missed Wall Street’s revenue estimates multiple times over the last two years.
Looking at Altria’s peers in the beverages, alcohol, and tobacco segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Vita Coco delivered year-on-year revenue growth of 28.1%, beating analysts’ expectations by 3%, and Philip Morris reported revenues up 10.4%, topping estimates by 5.5%. Vita Coco traded down 11.4% following the results while Philip Morris was up 1.6%.
Read our full analysis of Vita Coco’s results here and Philip Morris’s results here.
There has been positive sentiment among investors in the beverages, alcohol, and tobacco segment, with share prices up 4.5% on average over the last month. Altria is up 1% during the same time and is heading into earnings with an average analyst price target of $70.64 (compared to the current share price of $74.83).
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.